Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
The current Iovance Biotherapeutics(IOVA) stock price is $3.82, with a market capitalization of 1.71B. The stock trades at a price-to-earnings (P/E) ratio of -3.81.
As of 2026-05-11, Iovance Biotherapeutics(IOVA) stock has fluctuated between $3.55 and $3.83. The current price stands at $3.82, placing the stock +7.4% above today's low and -0.4% off the high.
Iovance Biotherapeutics(IOVA) shares are trading with a volume of 4.37M, against a daily average of 17.65M.
During the past year, Iovance Biotherapeutics(IOVA) stock moved between $1.64 at its lowest and $5.63 at its peak.
During the past year, Iovance Biotherapeutics(IOVA) stock moved between $1.64 at its lowest and $5.63 at its peak.
IOVA News
Iovance Biotherapeutics, Inc. ( ) missed earnings with its latest first-quarter results, disappointing overly-optimistic forecasters. It was a pretty negative r...
Iovance Biotherapeutics recently saw short interest in its shares fall and institutional investors increase their positions ahead of the company’s upcoming Q1 2...
Analyst ratings
73%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.